Featured Research

from universities, journals, and other organizations

Coupling Of Brain Proteins May Prompt New Treatments For Schizophrenia, Addiction: Study

Date:

January 20, 2000

Source:

University Of Toronto

Summary:

Researchers have discovered a cellular communication method in the brain -- a couple of two structurally different proteins -- that could lead to new therapeutic strategies for shizophrenia and addiction.

Share This

Researchers at the University of Toronto, the Centre for Addiction and Mental Health (CAMH) and the Hospital for Sick Children (HSC) have discovered a cellular communication method in the brain that could lead to improved treatments for schizophrenia and addiction.

Related Articles

Many of the symptoms associated with schizophrenia and addiction are caused by either too much or too little dopamine and GABA, chemicals in the brain that help regulate learning, memory, emotion and cognition. In a study published in the Jan. 20 edition of the journal Nature, researchers demonstrate how proteins can modify each other's function - including the ability of neurons to accept or reject dopamine and other neurochemicals - by binding to each other.

"What we found is a previously unknown method of signal transduction between two structurally different neurotransmitter receptor systems, that is, the direct physical coupling of these proteins," says senior author Dr. Hyman Niznik, associate professor of psychiatry and pharmacology at U of T and section head, laboratory and molecular neurobiology at CAMH. "This may provide us with a new therapeutic window on how to restore normal cellular function in diseases like schizophrenia with the right medication that can either block this interaction or make it happen."

Brain cells communicate with each other via neurotransmitters - natural chemicals that interact with proteins, or receptors, on adjacent neurons. There are many different types of receptors in the brain, some of which respond only to dopamine and some only to the neurotransmitter GABA [g-aminobutyric acid]. Of the many dopamine receptors, two - D1 and D5 - are very similar and respond to the same drugs. Many of the negative symptoms of schizophrenia and addiction are regulated by D1-like receptors.

Niznik and his team of researchers demonstrated that dopamine D5 receptors can directly modify the function of GABA receptors by directly binding to them and forming a receptor-receptor complex. "GABA receptors are structurally different from dopamine D5 receptors, and act as the major shutdown systems for virtually every part of the brain," says co-author Dr. Yu Wang, associate professor of laboratory medicine and pathobiology at U of T and scientist at HSC's research institute. Dopamine receptors were previously believed to be able to modify GABA receptors only by interacting with another protein, called G-proteins.

"We've shown how these two receptor proteins bind to each other in order to modify each other's function," Niznik says. "It's like cutting out the middle guy - you don't need the G-protein to let these receptors "talk" to each other. We believe this to be a very general phenomenon." Niznik expects to find many other pairs of brain cell surface receptors that physically couple to each other to regulate brain function.

The researchers believe this study also provides some answers as to why there are many different types of receptors - like D1 and D5 - that until now appeared to carry out the same function. "The same protein that turns cells on in one part of the brain can have little or no effect on another part, depending on which receptor it physically couples to," he says.

"Our next step will be to demonstrate that there is a malfunction in this coupling phenomenon between these neurotransmitter receptor proteins in the brains of schizophrenics," says lead author Dr. Fang Liu, research scientist at CAMH. The researchers believe this work will ultimately introduce a whole new field of study in signal transduction and molecular neuropsychiatry.

This study was funded by the Medical Research Council, the Ontario Mental Health Foundation, the Canadian Psychiatric Research Foundation, the National Institute of Drug Abuse and the C. Cleghorn Fellowship in Schizophrenia Research at U of T and CAMH.

University Of Toronto. "Coupling Of Brain Proteins May Prompt New Treatments For Schizophrenia, Addiction: Study." ScienceDaily. ScienceDaily, 20 January 2000. <www.sciencedaily.com/releases/2000/01/000114133531.htm>.

University Of Toronto. (2000, January 20). Coupling Of Brain Proteins May Prompt New Treatments For Schizophrenia, Addiction: Study. ScienceDaily. Retrieved March 3, 2015 from www.sciencedaily.com/releases/2000/01/000114133531.htm

University Of Toronto. "Coupling Of Brain Proteins May Prompt New Treatments For Schizophrenia, Addiction: Study." ScienceDaily. www.sciencedaily.com/releases/2000/01/000114133531.htm (accessed March 3, 2015).

More From ScienceDaily

More Mind & Brain News

Featured Research

Mar. 3, 2015 — No significant change in home habits of smokers have been observed in the aftermath of a ban on smoking in public spaces, researchers report. Greater inspiration to kick the habit likely comes from ... full story

Mar. 3, 2015 — Heart function has been associated with the development of dementia and Alzheimer's disease through a new study. Participants with decreased heart function, measured by cardiac index, were two to ... full story

Mar. 3, 2015 — Children of recently separated or divorced families are likelier to drink sugar-sweetened beverages than children in families where the parents are married, putting them at higher risk for obesity ... full story

Mar. 3, 2015 — Why do people shake hands? A new study suggests one of the reasons for this ancient custom may be to check out each other's odors. Even if we are not consciously aware of this, handshaking may ... full story

Mar. 3, 2015 — It appears that stress markers in unemployed people can be found, independent of smoking, alcohol consumption and overweight/obesity. Results from a study suggest that long-term unemployment may be ... full story

Mar. 3, 2015 — Doctors write millions of prescriptions a year for drugs to calm the behavior of people with Alzheimer’s disease and other types of dementia. But non-drug approaches actually work better, and carry ... full story

Mar. 3, 2015 — Briefly counseling college students on the dangers of binge drinking is effective in lowering heavy drinking levels among many students, but only temporarily. Three out of four will be right back ... full story

Mar. 3, 2015 — Loneliness brought about by the death of a spouse can trigger a wider network of depression-like symptoms, a study has found, but authors suggest that doctors are often too quick to attribute these ... full story

Mar. 3, 2015 — Family Based Interpersonal Psychotherapy (FB-IPT) is more effective in treating preadolescent children with depression compared to child-centered therapy (CCT), a recent study has found. ... full story

Mar. 3, 2015 — Everyone worries about losing their memory as they grow older—memory loss remains one of the most common complaints of the elderly. But the molecular reasons behind the processes remain unclear, ... full story

Related Stories

Sep. 10, 2013 — Neuroscientists have made a remarkable new discovery revealing the underlying molecular process by which opiate addiction develops in the brain. Opiate addiction is largely controlled by the ... full story

Jan. 11, 2012 — New research provides fascinating insight into a newly discovered brain mechanism that limits the rewarding impact of cocaine. The study describes protective delayed mechanism that turns off the ... full story

ScienceDaily features breaking news and videos about the latest discoveries in health, technology, the environment, and more -- from major news services and leading universities, scientific journals, and research organizations.